Protein kinase CKII (CKII) is required for progression through the cell division cycle. We recently reported that the β subunit of protein kinase CKII (CKIIβ) associates with CKBBP1 that contains the Ring-H2 finger motif in the yeast two-hybrid system. We demonstrate here that the Ring-H2 finger-disrupted mutant of CKBBP1 does not interact with purified CKIIβ in vitro, which shows that the Ring-H2 finger motif is critical for direct interaction with CKIIβ. The CKII holoenzyme is efficiently co-precipitated with the wild-type CKBBP1, but not with the Ring-H2 finger-disrupted CKBBP1, from whole cell extracts when epitope-tagged CKBBP1 is transiently expressed in HeLa cells. Disruption of the Ring-H2 finger motif does not affect the cellular localization of CKBBP1 in HeLa cells. The increased expression of either the wild-type CKBBP1 or Ring-H2 finger-disrupted CKBBP1 does not modulate the protein or the activity levels of CKII in HeLa cells. However, the stable expression of Ring-H2 finger-disrupted CKBBP1 in HeLa cells suppresses cell proliferation and causes the accumulation of the G1/G0 peak of the cell cycle. The Ring-H2 finger motif is required for maximal CKBBP1 phosphorylation by CKII, suggesting that the stable binding of CKBBP1 to CKII is necessary for its efficient phosphorylation. Taken together, these results suggest that the complex formation of CKIIβ with CKBBP1 and/or CKII-mediated CKBBP1 phosphorylation is important for the G1/S phase transition of the cell cycle.
Materials and Methods
Antibodies $ SRO\FORQDO DQWL&.%%3 DQWLERG\ ZDV UDLVHG DJDLQVWUHFRPELQDQW&.%%3DVGHVFULEHGHOVHZKHUH6RQ HWDO 7KH SRO\FORQDO DQWL&.,,α DQG PRQRFORQDO DQWL&.,,β DQWLERGLHVZHUHREWDLQHGIURP&DOELRFKHP/D-ROOD86$ Site-directed mutagenesis and plasmid constructions The bacterial expression vector pET14b-CKBBP1, which expresses the full-length CKBBP1 with a hexahistidine (His) tag to the amino terminus, was described previously (Son et al., 1999) . To replace both Cys 80 and His 82 within the Ring-H2 finger motif of CKBBP1 with Ala, an overlap extension PCR was performed as described (Ho et al., 1989) . The desired mutations were incorporated into oligonucleotide primers. Two initial PCRs were performed with either the N-terminal forward (N) primer (5'-CGGCCATATGGCCGACGTGGAAGACGG-3') and mutagenic reverse primer (5'-AGTTGTGGAAGGATGCATTTGCTTCTCCC CAGA-3'), or the mutagenic forward primer (5'-TCTGGGGA GAAGCAAATGCATCCTTCCACA-3') and C-terminal reverse (C) primer (5'-CTAACTCGAGTCATTTGCCGATTCTTTGGA-3'). Equal amounts of these two PCR products were mixed, denatured, reannealed, then applied to a second PCR using the N and C primers. After digestion of the PCR products with NdeI/XhoI, the fragment was ligated into the NdeI/XhoI sites of pET14b.
To generate a Myc-His-tagged CKBBP1 expression construct, the CKBBP1 cDNA was PCR-amplified using the primers 5'-CCGGAATTCCGCCATGGCCGACGTGGAAGA-3' and 5'-GCG GGATCCATTTGCCGATTCTTTGGACCA-3'. The PCR fragment was digested with EcoRI and BamHI, then subcloned into the EcoRI-and BamHI-digested pcDNA3.1/Myc-His vectors (Invitrogene, Carlsbad, USA). To generate a green fluorescent protein (GFP)-tagged CKBBP1 expression construct, the CKBBP1 cDNA was PCR-amplified using the primers 5'-CGCGGCCTCGA GATGGCCGACGTGGAAG-3' and 5'-CTATCGGATCCCCTTT GCCGATTCTTTG-3'. The PCR fragment was digested with XhoI and BamHI, then subcloned into XhoI-and BamHI-digested pEGFP-N1 vectors (Clontech, Palo Alto, USA). The construct sequences were confirmed by nucleotide sequencing. To transiently express the Myc-His-tagged CKBBP1 in cells, the HeLa cells were transfected with the Myc-His-tagged CKBBP1 constructs using Lipofectamine (Qiagen, Hilden, Germany), as described by the manufacturer. At 12 h after the transfection, the medium was changed, and the cells were grown for another 36 h before being harvested. To establish CKBBP1-expressing stable cell lines, the HeLa cells were transfected with the Myc-His-tagged CKBBP1 constructs or the vector control by Lipofectamine. One day later, the cells were cultured in the presence of 1 mg/ml G418. After 2 weeks, the clones were picked and grown in the same medium in the presence of 100 µg/ml G418. Stable clones were examined for protein expression by Western blotting. 
Purification

Preparation of HeLa cell extract
Subcellular localization of CKBBP1
To determine the subcellular localization of the wild-type and mutant CKBBP1, the GFP-tagged CKBBP1 was transiently-expressed in HeLa cells. Green fluorescence images were obtained using a confocal microscope after 48 h of transfection.
Growth curves
The HeLa cells that stably expressed the wildtype or mutant CKBBP1 were seeded in six-well dishes at a starting density of 5,000 cells/well; duplicate wells were used for each cell line. Every 48 h, the cells were trypsinized and counted in triplicate using a hemocytometer. Trypan blue was used to distinguish the After an extensive wash, the immobilized complexes were recovered by an elution step that was performed in the presence of 200 mM imidazole. The proteins were separated by 15% (w/v) SDS-polyacrylamide gel electrophoresis, and visualized by Western blotting with anti-CKIIβ or anti-CKBBP1 antibodies. Lane 1, the CKIIβ protein was incubated with the control Ni-NTA agarose beads. 
Results and Discussion
Ring-H2 finger motif of CKBBP1 is critical for direct interaction with CKIIβ in vitro Direct CKBBP1 interaction with the β subunit of CKII was further tested in vitro using a hexahistidine (His) pull-down assay. The purified His-CKBBP1 fusion protein was immobilized on Ni-NTA agarose beads and incubated with the purified CKIIβ protein.
The beads were washed, and the bound CKIIβ protein was visualized by Western blotting with an anti-CKIIβ antibody. As shown in Figure 1 (lanes 1 and 2) . The empty vector (pcDNA3.1/ Myc-His) was used as the control. The Myc-His tag that was incorporated into the CKBBP1 sequence permitted the precipitation of the exogenously expressed CKBBP1 with the Ni-NTA agarose. At 48 h after transfection, the cells were harvested, and the Myc-His-CKBBP1 expression was detected by co-precipitation experiments with Ni-NTA agarose and Western blotting using anti-CKBBP1 antibody. As shown in Figure 2A , Myc-His-tagged CKBBP1 proteins were detected in the HeLa cells that were transfected with pcDNA3.1/Myc-His-CKBBP1, but not with the pcDNA3.1/Myc-His vector alone. Western blots of the co-precipitates that were probed the anti-CKIIβ antibody showed that CKIIβ were co-precipitated with the wild-type CKBBP1 in the HeLa cells that were transfected with the pcDNA3.1/Myc-His-CKBBP1
WT . This indicates that the wild-type CKBBP1 interacts with CKIIβ in HeLa cells. In contrast to the in vitro experiment, a small amount of CKIIβ was detectable in the Ni-resin precipitates from the HeLa cells that were transfected with the pcDNA3.1/Myc-His-CKBBP1 C80A/H82A
. Quantification by a densitometer analysis revealed that the disruption of the Ring-H2 finger motif reduced the binding of CKBBP1 to CKIIβ 3.5-fold. The negativecontrol precipitation with an irrelevant resin (amylose resin) did not bring down the CKBBP1-CKII complex from the HeLa cells that were transfected with the pcDNA3.1/Myc-His-CKBBP1.
Western blots of these co-precipitates that were probed the anti-CKIIα antibody showed that CKIIα co-precipitated with the wild-type CKBBP1, which demonstrates that the wildtype CKBBP1 interacts with the CKII holoenzyme, as well as the CKIIβ subunit ( Fig. 2A) . Using the synthetic peptide substrate RRREEETEEE, the phosphotransferase activity of . After 48 h of transfection, green fluorescence images were obtained using a confocal microscope. the CKII holoenzyme in CKBBP1 co-precipitates was also determined. CKII activity was highly detected in the CKBBP1 WT co-precipitates from the HeLa cells that were transfected with the pcDNA3.1/Myc-His-CKBBP1 WT . However, the CKBBP1 C80A/H82A co-precipitates contained only 30% of CKII activity in the CKBBP1
WT co-precipitates. CKII activity was only slightly detected in the Ni-resin precipitates from the HeLa cells that were transfected with pcDNA3.1/ Myc-His, and in the amylose resin precipitates from the HeLa cells that were transfected with pcDNA3.1/Myc-His-CKBBP1 WT (Fig. 2B) . These experimental results show that the wild-type CKBBP1 interacts with endogenous CKIIβ, as well as the CKII holoenzyme in HeLa cells. Preferential interaction of CKII with CKBBP1
WT to CKBBP1 C80A/H82A indicates that the Ring-H2 finger motif of CKBBP1 is involved in CKIIβ-binding in HeLa cells. WT did not change cell proliferation. However, the stable expression of Myc-His-CKBBP1 C80A/H82A induced an apparent decrease in cell proliferation over the time course (Fig. 6A) . A FACS analysis was employed to examine whether the stable expression of Myc-His-CKBBP1 C80A/H82A interferes with cell cycle progression. As shown in Figure 6B , the increased expression of Myc-His-CKBBP1
WT caused no detectable change in the cell cycle profile. However, the accumulation of the G1/G0 peak was observed with the stable expression of Myc-His-CKBBP1 C80A/H82A
. These results indicate that the Ring-H2 finger motif of CKBBP1 plays an important role in the G1/S phase transition of the cell cycle in HeLa cells.
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